Deep Tech Startups

Quasar is a distributed time-series database that combines live data ingestion, deep historical storage, and heavy analytics on the same dataset, making new data queryable as it arrives without warehouse loading cycles. It targets high-precision, high-volume workloads in aerospace and defense, finance, industry, and scientific research.

1 investor

Qubigen provides end-to-end AI drug design as a service, using a global federated AI system and computational workflows to generate and optimize novel drug candidates for specific protein targets. Its federated approach draws insights from clients' protected, sensitive data without moving or viewing it, serving pharmaceutical and drug discovery researchers.

1 investor

Qubitrium is a company focused on quantum technology innovation. The page provides no further detail on its specific products or target customers.

1 investor

Quemix develops quantum computing algorithms, software, and quantum sensor research to enable breakthrough innovations across industries including automotive, semiconductors, pharmaceuticals, aerospace, logistics, and finance. The company supports leading technology enterprises in adopting and integrating quantum technology into their existing services and applications.

1 investor

Quest Global offers end-to-end Product Lifecycle Management (PLM) and digitization services for engineering companies, leveraging AI and low-code technologies to optimize product development from concept through operations. The company provides consulting, system integration, customization, support, and data connectivity solutions across multiple industries.

1 investor

Quicksilver Biosciences is developing a CMOS-integrated biosensor platform that uses proprietary sensing techniques to reach higher sensitivity in a portable, lower-cost form factor. The company is currently operating in stealth mode.

1 investor

Quinn is an AI research service that synthesizes biological, clinical, and competitive evidence from published literature and databases to answer drug development questions for biotech companies. It delivers structured, traceable evidence packages for decisions across target validation, indication prioritization, biomarker strategy, and trial design.

1 investor

Quintrans Hyperloop is developing a track-based linear induction motor system with proprietary control software to automate container movement at ports, and is building a 100-meter commercial-scale test track as a demonstrator. The company is focused on port automation in India.

1 investor

QuiX Quantum develops Carina, a room-temperature photonic quantum computer that integrates photon generation, photonic processing, switching, cluster-state generation, detection, and feed-forward control into a deployable system. The product targets researchers and organizations seeking scalable, fault-tolerant quantum computing capabilities.

1 investor

Qunett develops modular quantum networking hardware, including photonic entanglement sources and diamond-based quantum memory modules, to form the physical layer for secure, large-scale quantum communication. Its platform-agnostic technology targets quantum computing, PNT and sensor networks, and securing classical data channels.

1 investor

Quotient is a biotechnology company applying somatic genetics research to R&D, developing its work through a proprietary platform. It was founded by Flagship Pioneering in collaboration with academic co-founders.

1 investor

Quside develops quantum random number generator (QRNG) technology that produces certified, observable random numbers meeting NIST SP800-90B standards, used to strengthen digital trust and support quantum-safe cybersecurity. It serves enterprise, telecom, data center, and research customers transitioning to post-quantum security and randomized accelerated computation.

1 investor

Ideas Lab is an applied research laboratory that develops quantum sensing technologies and prototypes, working to bring quantum science breakthroughs from academic research to commercial-ready products and new businesses in Canada.

1 investor

Qvyon builds MIMIC, a neural reconstruction platform that turns limited real sensor logs (camera, radar, LiDAR, fusion) into high-fidelity 3D/4D scenario reconstructions and coverage-driven variants for validating physical AI and autonomous systems. It produces versioned, traceable test assets with provenance and uncertainty signals for training, validation, and regression release gates.

1 investor

Qwake develops an intelligence platform using edge AI and sensor technology to provide real-time operational awareness and coordination for high-risk physical operations, with initial focus on the firefighting industry.

1 investor

qWave is a rock mechanics technology company developing a patented tool that uses focused acoustic shockwaves to create wellbore perforations for more accurately measuring rock stress properties. Its technology serves operators of oil & gas and carbon storage wells and projects.

1 investor

R2 Semiconductor develops power management semiconductor technology, including envelope tracking for RF power amplifiers and core power management for multi-core application processors and digital SoCs. Its products aim to improve power efficiency, reduce heat, and shrink form factors for chip and device developers.

1 investor

RaceRocks is a woman-led, Indigenous-owned company that modernizes training programs for the defence, aerospace, and marine sectors through immersive technologies including VR, AR, and simulation. The company develops 3D digital assets, interactive content, and curriculum solutions to improve workforce readiness and reduce training costs.

1 investor

Ractigen Therapeutics develops proprietary RNA delivery platforms for oligonucleotide therapeutics, enabling treatment of previously unreachable tissues and organs in the CNS and beyond the liver. The company's platforms support clinical development of RNA-based therapies through simplified manufacturing processes.

1 investor

Radical is a venture capital firm that invests in artificial intelligence companies, backing founders from early incubation through growth and pre-IPO stages. Its portfolio spans AI infrastructure, robotics, quantum computing, biotech, and climate technology.

1 investor

Radiogenesis builds an end-to-end computational pipeline that uses AI, protein engineering, and radiochemistry to design and optimize novel targeted radioligand therapies for patients with metastatic cancers. Its platform generates and validates candidate molecules through a lab-in-the-loop process and is isotope agnostic, starting with Actinium-225 and Lutetium-177.

1 investor

Radisys provides open telecom solutions and integration services, offering disaggregated platforms built on open standards, software, and hardware. Its portfolio covers digital endpoints, open broadband and wireless access across terrestrial, non-terrestrial, and edge environments, and digital engagement platforms, serving service providers.

1 investor

Radix Labs builds operating-system software for biology laboratories to run and automate their lab workflows. It serves life-science and biotech labs.

1 investor

RadixArk is a deep-tech company building large-scale AI inference and training infrastructure, including open-source engines and managed tooling for serving and post-training models. It targets developers, startups, enterprises, and research labs building AI systems, with a focus on open, low-cost infrastructure.

1 investor